F. Märki

1.8k total citations
46 papers, 1.5k citations indexed

About

F. Märki is a scholar working on Molecular Biology, Physiology and Surgery. According to data from OpenAlex, F. Märki has authored 46 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Biology, 7 papers in Physiology and 6 papers in Surgery. Recurrent topics in F. Märki's work include Protein Kinase Regulation and GTPase Signaling (19 papers), Nitric Oxide and Endothelin Effects (5 papers) and Pancreatic function and diabetes (5 papers). F. Märki is often cited by papers focused on Protein Kinase Regulation and GTPase Signaling (19 papers), Nitric Oxide and Endothelin Effects (5 papers) and Pancreatic function and diabetes (5 papers). F. Märki collaborates with scholars based in Switzerland, United States and Czechia. F. Märki's co-authors include Josef Pfeilschifter, H. van den Bosch, W. Pignat, Casper G. Schalkwijk, Klaus Vosbeck, Richard Franson, Josef Pfeilschifter, Bernhard Witkop, Andreas Fredenhagen and Jan van Oostrum and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Biochemical Journal.

In The Last Decade

F. Märki

45 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Märki Switzerland 24 892 218 213 189 172 46 1.5k
Kent L. Erickson United States 23 907 1.0× 323 1.5× 235 1.1× 121 0.6× 126 0.7× 59 2.0k
M A Clark United States 21 920 1.0× 326 1.5× 393 1.8× 166 0.9× 185 1.1× 43 1.6k
Michelle V. Winstead United States 9 971 1.1× 222 1.0× 187 0.9× 227 1.2× 231 1.3× 9 1.5k
Robert W. Wrenn United States 21 1.1k 1.3× 195 0.9× 220 1.0× 123 0.7× 79 0.5× 39 1.8k
B Thiele Germany 21 1.3k 1.5× 230 1.1× 197 0.9× 206 1.1× 176 1.0× 57 2.0k
Hitoshi Yagisawa Japan 30 1.6k 1.8× 305 1.4× 233 1.1× 145 0.8× 165 1.0× 112 2.6k
I Kudo Japan 16 796 0.9× 324 1.5× 210 1.0× 247 1.3× 396 2.3× 29 1.6k
Diane S. Keeney United States 25 706 0.8× 146 0.7× 142 0.7× 387 2.0× 139 0.8× 52 1.9k
Claude Aussel France 25 920 1.0× 603 2.8× 181 0.8× 176 0.9× 71 0.4× 103 1.8k
Hideki Ito Japan 23 891 1.0× 206 0.9× 413 1.9× 131 0.7× 108 0.6× 42 1.9k

Countries citing papers authored by F. Märki

Since Specialization
Citations

This map shows the geographic impact of F. Märki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Märki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Märki more than expected).

Fields of papers citing papers by F. Märki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Märki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Märki. The network helps show where F. Märki may publish in the future.

Co-authorship network of co-authors of F. Märki

This figure shows the co-authorship network connecting the top 25 collaborators of F. Märki. A scholar is included among the top collaborators of F. Märki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Märki. F. Märki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Märki, F., Werner Breitenstein, R. Bernasconi, et al.. (1993). Differential inhibition of human secretory and cytosolic phospholipase A2. Inflammation Research. 38(1-2). 202–211. 16 indexed citations
2.
Märki, F., et al.. (1993). Recombinant Human Synovial Fluid Phospholipase A2 and N-Terminal Variant: Kinetic Parameters and Response to Inhibitors. The Journal of Biochemistry. 113(6). 734–737. 6 indexed citations
3.
Märki, F., et al.. (1993). Phospholipase A2 Activity in Serum of Neuroleptic-Naive Psychiatric Inpatients. Pharmacopsychiatry. 26(3). 94–98. 35 indexed citations
4.
Pfeilschifter, Josef, Heiko Mühl, W. Pignat, F. Märki, & H. van den Bosch. (1993). Cytokine regulation of Group II phospholipase A2 expression in glomerular mesangial cells. European Journal of Clinical Pharmacology. 44(S1). S7–S9. 24 indexed citations
5.
Schalkwijk, Casper G., Josef Pfeilschifter, F. Märki, & H. van den Bosch. (1992). Interleukin-1 beta- and forskolin-induced synthesis and secretion of group II phospholipase A2 and prostaglandin E2 in rat mesangial cells is prevented by transforming growth factor-beta 2.. Journal of Biological Chemistry. 267(13). 8846–8851. 66 indexed citations
6.
Mühl, Heiko, Thomas Geiger, W. Pignat, et al.. (1992). Transforming growth factors type‐β and dexamethasone attenuate group II phospholipase A2 gene expression by interleukin‐1 and forskolin in rat mesangial cells. FEBS Letters. 301(2). 190–194. 36 indexed citations
7.
Marco, Stefania Di, F. Märki, Hans Hofstetter, et al.. (1992). Purification, Analysis, and Enzymatic Activity of Recombinant Human Synovial Fluid Phospholipase A2 and N-Terminal Variants. The Journal of Biochemistry. 112(3). 350–354. 21 indexed citations
8.
Schalkwijk, Casper G., Margriet J. Vervoordeldonk, Josef Pfeilschifter, F. Märki, & H. van den Bosch. (1991). Cytokine-and forskolin-induced synthesis of group II phospholipase A2 and prostaglandin E2 in rat mesangial cells is prevented by dexamethasone. Biochemical and Biophysical Research Communications. 180(1). 46–52. 48 indexed citations
9.
10.
Schalkwijk, Casper G., Josef Pfeilschifter, F. Märki, & H. van den Bosch. (1991). Interleukin-1β, tumor necrosis factor and forskolin stimulate the synthesis and secretion of group II phospholipase A2 in rat mesangial cells. Biochemical and Biophysical Research Communications. 174(1). 268–275. 96 indexed citations
11.
Märki, F., Josef Pfeilschifter, H Rink, & Irmgard Wiesenberg. (1990). ‘Antiflammins’: Two nonapeptide fragments of uteroglobin and lipocortin I have no phospholipase A2 ‐inhibitory and anti‐inflammatory activity. FEBS Letters. 264(2). 171–175. 32 indexed citations
12.
Pfeilschifter, Josef, et al.. (1990). cAMP potentiates interleukin 1- and tumor necrosis factor-stimulated phospholipase A2 secretion from rat renal mesangial cells. Fresenius Journal of Analytical Chemistry. 337(1). 139–140. 5 indexed citations
13.
Pfeilschifter, Josef, W. Pignat, Klaus Vosbeck, & F. Märki. (1989). Interleukin 1 and tumor necrosis factor synergistically stimulate prostaglandin synthesis and phospholipase A2 release from rat renal mesangial cells. Biochemical and Biophysical Research Communications. 159(2). 385–394. 171 indexed citations
14.
Pfeilschifter, Josef, W. Pignat, Klaus Vosbeck, F. Märki, & Irmgard Wiesenberg. (1989). Susceptibility of interleukin 1- and tumour necrosis factor-induced prostaglandin E2 and phospholipase A2 release from rat renal mesangial cells to different drugs. Biochemical Society Transactions. 17(5). 916–917. 12 indexed citations
15.
Pfeilschifter, Josef, W. Pignat, F. Märki, & Irmgard Wiesenberg. (1989). Release of phospholipase A2 activity from rat vascular smooth muscle cells mediated by cAMP. European Journal of Biochemistry. 181(1). 237–242. 39 indexed citations
16.
Bronner, Christian, Didier Monté, F. Märki, et al.. (1987). Compound 48/80 is a potent inhibitor of phospholipase C and a dual modulator of phospholipase A2 from human platelet. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 920(3). 301–305. 54 indexed citations
17.
Wenk, P., et al.. (1987). CGP 35949: a potent leukotriene antagonist and inhibitor of phospholipase. Biological profile.. PubMed. 17A. 526–31. 1 indexed citations
18.
Eisler, K., B. Kamber, B. Riniker, et al.. (1979). Synthesis and biological activity of five d-Cys analogs of human insulin. Bioorganic Chemistry. 8(4). 443–450. 5 indexed citations
19.
Märki, F. & Bernhard Witkop. (1963). The venom of the Colombian arrow poison frogPhyllobates bicolor. Cellular and Molecular Life Sciences. 19(7). 329–338. 63 indexed citations
20.
Märki, F., Julius Axelrod, & Bernhard Witkop. (1962). Catecholamines and methyltransferases in the South American toad (Bufo marinus). Biochimica et Biophysica Acta. 58(2). 367–369. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kent L. Erickson Breakdown of academic impact, for papers by M A Clark Breakdown of academic impact, for papers by Michelle V. Winstead Breakdown of academic impact, for papers by Robert W. Wrenn Breakdown of academic impact, for papers by B Thiele Breakdown of academic impact, for papers by Hitoshi Yagisawa Breakdown of academic impact, for papers by I Kudo Breakdown of academic impact, for papers by Diane S. Keeney Breakdown of academic impact, for papers by Claude Aussel Breakdown of academic impact, for papers by Hideki Ito
Rankless by CCL
2026